Alert: Rating Downgrade (4/19/24)-Neurocrine Biosciences Inc (NASDAQ: NBIX).
Stock Rating Downgrade In recent days the Value Trend Rating for Neurocrine Biosciences Inc (NASDAQ: NBIX) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Neurocrine Biosciences Inc (NASDAQ: […]